
Abbott Reports Results of High Sensitive Troponin-I Blood Test for Risk Assessment of Heart Diseases
Shots:
- The Atherosclerosis Risk in Communities (ARIC) study results involves assessing of high-sensitive troponin-I blood test in 8-121 candidates with no known cardiovascular disease aged 54-73yrs. for 15yrs.
- The ARIC study results identified the risk of cardiac events by measuring the elevated troponin-I levels- 85% had detectable troponin- adults with high troponin-I level are twice- thrice & 4times likely to have cardiac disease events- ischemic stroke & hospitalized with heart failure respectively
- Abbott's diagnostic test is the troponin-I blood test with a CE mark- predicts the risk of developing heart disease by measuring heart-specific proteins called troponins. Abbott is pursuing registration for the test in the US
Click here to read full press release/ article
Ref: Abbott | Image: Abbott

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com